Nathan Weinstein
Stock Analyst at Aegis Capital
(0.27)
# 4,403
Out of 5,115 analysts
59
Total ratings
13.79%
Success rate
-24.81%
Average return
Main Sectors:
Stocks Rated by Nathan Weinstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVGN Evogene | Maintains: Buy | $100 → $80 | $1.01 | +7,820.79% | 2 | Sep 12, 2022 | |
| DRIO DarioHealth | Maintains: Buy | $400 → $300 | $10.30 | +2,812.62% | 6 | Aug 18, 2022 | |
| VNRX VolitionRx | Maintains: Buy | $9 → $6 | $0.25 | +2,289.49% | 5 | Aug 15, 2022 | |
| IMUX Immunic | Maintains: Buy | $40 → $35 | $0.61 | +5,637.70% | 2 | Aug 8, 2022 | |
| STXS Stereotaxis | Initiates: Buy | $6 | $2.33 | +157.51% | 1 | Jul 12, 2022 | |
| ORMP Oramed Pharmaceuticals | Maintains: Buy | $35 → $30 | $3.42 | +777.19% | 5 | May 16, 2022 | |
| TRVI Trevi Therapeutics | Initiates: Buy | $10 | $10.70 | -6.54% | 1 | Mar 29, 2022 | |
| MDWD MediWound | Maintains: Buy | $63 → $49 | $17.61 | +178.25% | 4 | Mar 21, 2022 | |
| ENVB Enveric Biosciences | Downgrades: Hold | $63,000 → $1,800 | $3.07 | +58,531.92% | 2 | Mar 8, 2022 | |
| CING Cingulate | Initiates: Buy | $2,160 | $5.72 | +37,662.24% | 1 | Jan 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $120 | $1.56 | +7,592.31% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $0.78 | +1,182.05% | 2 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $24.97 | +124.27% | 2 | Sep 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $27 | $3.84 | +603.13% | 3 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $0.74 | +4,626.54% | 4 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.46 | +721.92% | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $30.02 | +149.83% | 1 | Jan 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $104 → $88 | $2.39 | +3,582.01% | 3 | Oct 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $180 | $0.54 | +33,159.42% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $135 | $8.39 | +1,509.06% | 3 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $6.04 | +131.79% | 1 | Jul 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $220 | $15.42 | +1,326.72% | 7 | May 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8.5 | $3.10 | +174.19% | 1 | Mar 23, 2020 |
Evogene
Sep 12, 2022
Maintains: Buy
Price Target: $100 → $80
Current: $1.01
Upside: +7,820.79%
DarioHealth
Aug 18, 2022
Maintains: Buy
Price Target: $400 → $300
Current: $10.30
Upside: +2,812.62%
VolitionRx
Aug 15, 2022
Maintains: Buy
Price Target: $9 → $6
Current: $0.25
Upside: +2,289.49%
Immunic
Aug 8, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $0.61
Upside: +5,637.70%
Stereotaxis
Jul 12, 2022
Initiates: Buy
Price Target: $6
Current: $2.33
Upside: +157.51%
Oramed Pharmaceuticals
May 16, 2022
Maintains: Buy
Price Target: $35 → $30
Current: $3.42
Upside: +777.19%
Trevi Therapeutics
Mar 29, 2022
Initiates: Buy
Price Target: $10
Current: $10.70
Upside: -6.54%
MediWound
Mar 21, 2022
Maintains: Buy
Price Target: $63 → $49
Current: $17.61
Upside: +178.25%
Enveric Biosciences
Mar 8, 2022
Downgrades: Hold
Price Target: $63,000 → $1,800
Current: $3.07
Upside: +58,531.92%
Cingulate
Jan 11, 2022
Initiates: Buy
Price Target: $2,160
Current: $5.72
Upside: +37,662.24%
Dec 7, 2021
Initiates: Buy
Price Target: $120
Current: $1.56
Upside: +7,592.31%
Nov 1, 2021
Maintains: Buy
Price Target: $9 → $10
Current: $0.78
Upside: +1,182.05%
Sep 9, 2021
Maintains: Buy
Price Target: $60 → $56
Current: $24.97
Upside: +124.27%
Aug 17, 2021
Maintains: Buy
Price Target: $26 → $27
Current: $3.84
Upside: +603.13%
Jun 7, 2021
Maintains: Buy
Price Target: $40 → $35
Current: $0.74
Upside: +4,626.54%
Mar 22, 2021
Initiates: Buy
Price Target: $12
Current: $1.46
Upside: +721.92%
Jan 26, 2021
Initiates: Buy
Price Target: $75
Current: $30.02
Upside: +149.83%
Oct 19, 2020
Maintains: Buy
Price Target: $104 → $88
Current: $2.39
Upside: +3,582.01%
Oct 8, 2020
Initiates: Buy
Price Target: $180
Current: $0.54
Upside: +33,159.42%
Aug 3, 2020
Maintains: Buy
Price Target: $195 → $135
Current: $8.39
Upside: +1,509.06%
Jul 13, 2020
Initiates: Buy
Price Target: $14
Current: $6.04
Upside: +131.79%
May 4, 2020
Maintains: Buy
Price Target: $180 → $220
Current: $15.42
Upside: +1,326.72%
Mar 23, 2020
Initiates: Buy
Price Target: $8.5
Current: $3.10
Upside: +174.19%